Discover 878 paid clinical trials in Kentucky. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Kentucky presents diverse clinical research opportunities for healthy volunteers looking to get involved in paid studies, and those with specific health conditions alike. Major research centers in Louisville, Lexington, and Bowling Green are actively seeking participants, offering access to new treatments and advanced medical care.
Filter
1
Filter results
Results: 878
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
for
Non Small Cell Lung Cancer, Esophageal Cancer,
Location: Boston MA, New Haven CT, New York NY,
Sponsor: SystImmune Inc.
Sex: All
Age: 18+
Code: NCT05983432
Phase 1, Recruiting
The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients
for
Arrythmia, Cardiomyopathies
Location: Boston MA, New York NY, Philadelphia PA, Baltimore MD,
Sponsor: University of Rochester
Sex: All
Age: 18+
Code: NCT05034432
Recruiting
Tracking Results of Ablations to Combat AF Registry Generation 2
for
Atrial Fibrillation
Location: Halifax, Brooklyn NY, Poughkeepsie NY,
Sponsor: AtriCure, Inc.
Sex: All
Age: 18+
Code: NCT05111015
Recruiting
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Ventral or Inguinal Hernia, Robotically Repaired With OviTex Mesh
for
Hernia, Ventral, Hernia, Inguinal
Location: Louisville KY, Traverse City MI, Mobile AL
Sponsor: Tela Bio Inc
Sex: All
Age: 21+
Code: NCT04779918
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
for
Neuroendocrine Tumors Unresectable,
Location: Baltimore MD, Fairfax VA, Chapel Hill NC, Miami FL,
Sponsor: Perspective Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT05636618
Phase 1, Phase 2, Recruiting
The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
for
Coronary Artery Disease, Heart Failure Systolic
Location: Halifax, New Haven CT, Quebec, Montreal, Baltimore MD,
Sponsor: Sunnybrook Health Sciences Centre
Sex: All
Age: 18+
Code: NCT05427370
Recruiting
Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
for
Ulcerative Colitis
Location: Boston MA, Lebanon NH, Syracuse NY, Miami FL,
Sponsor: Northwestern University
Sex: All
Age: 18 - 70+
Code: NCT05987852
Recruiting
Prospective US Radiofrequency SUI Trial
for
Urinary Incontinence, Stress
Location: Garden City NY, Jenkintown PA, Philadelphia PA,
Sponsor: Viveve Inc.
Sex: Female
Age: 18+
Code: NCT04720352
Recruiting
The Ailliance Post-Market Clinical Study
for
Spinal Deformity, Spinal Degenerative Disorder,
Location: Providence RI, New Brunswick NJ, Baltimore MD,
Sponsor: Medtronic Spinal and Biologics
Sex: All
Age: 18+
Code: NCT05856370
Recruiting
Efficacy of Iocide Oral Rinse Against Gingival Inflammation
for
Gingivitis, Investigation of Biological Markers of Inflammation
Location: Lexington KY
Sponsor: Biomedical Development Corporation
Sex: All
Age: 18+
Code: NCT01782170
Phase 2, Recruiting
Safety, Pharmacokinetics (PK), and Efficacy of ONC 841 in Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Philadelphia PA, Kissimmee FL, Gainesville FL,
Sponsor: OncoC4, Inc.
Sex: All
Age: 18+
Code: NCT06352359
Phase 1, Recruiting
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Providence RI, New York NY, Baltimore MD,
Sponsor: International Spine Study Group Foundation
Sex: All
Age: 18+
Code: NCT04194138
Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
for
Non-small Cell Lung Cancer
Location: Sydney, Saint John, Scarborough ME, West Haven CT,